Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 224.91 billion. The enterprise value is 242.12 billion.

Market Cap	224.91B
Enterprise Value	242.12B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.48B

Valuation Ratios

The trailing PE ratio is 16.58 and the forward PE ratio is 23.82.

PE Ratio	16.58
Forward PE	23.82
PS Ratio	4.66
PB Ratio	5.83
P/TBV Ratio	20.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	17.85
EV / Sales	5.02
EV / EBITDA	11.34
EV / EBIT	13.33
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.80
Debt / EBITDA	1.44
Debt / FCF	n/a
Interest Coverage	18.06

Financial Efficiency

Return on equity (ROE) is 37.17% and return on invested capital (ROIC) is 28.30%.

Return on Equity (ROE)	37.17%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	28.30%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	7.34%
Revenue Per Employee	652,746
Profits Per Employee	183,280
Employee Count	74,000
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Merck & Co. has paid 2.08 billion in taxes.

Income Tax	2.08B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has decreased by -14.68% in the last 52 weeks. The beta is 0.67, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-14.68%
50-Day Moving Average	46.14
200-Day Moving Average	53.50
Relative Strength Index (RSI)	55.82
Average Volume (20 Days)	168,215

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.07

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 48.30 billion and earned 13.56 billion in profits. Earnings per share was 5.41.

Revenue	48.30B
Gross Profit	37.23B
Operating Income	18.21B
Pretax Income	15.65B
Net Income	13.56B
EBITDA	21.40B
EBIT	18.21B
Earnings Per Share (EPS)	5.41

Full Income Statement

Balance Sheet

The company has 13.53 billion in cash and 30.74 billion in debt, with a net cash position of -17.21 billion.

Cash & Cash Equivalents	13.53B
Total Debt	30.74B
Net Cash	-17.21B
Net Cash Per Share	n/a
Equity (Book Value)	38.57B
Book Value Per Share	15.49
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.08%, with operating and profit margins of 37.69% and 28.08%.

Gross Margin	77.08%
Operating Margin	37.69%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.30%
EBIT Margin	37.69%
FCF Margin	n/a

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.34%
Shareholder Yield	1.34%
Earnings Yield	6.03%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1